Eledon Pharmaceuticals (ELDN) Other Working Capital Changes (2013 - 2026)

Eledon Pharmaceuticals (ELDN) has 8 years of Other Working Capital Changes data on file, last reported at -$86000.0 in Q1 2026.

• Quarterly Other Working Capital Changes fell 16.22% year-over-year to -$86000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$325000.0 (down 3.5% YoY) and the FY2025 annual result came in at -$313000.0, up 7.67% from the prior year.
• Other Working Capital Changes slipped to -$86000.0 in Q1 2026, from -$81000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $1.6 million in Q4 2023 to a low of -$1.4 million in Q2 2024.
• A 5-year average of -$73588.2 and a median of -$338000.0 in 2024 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes sank 97.83% — and 2024, when it increased 28.72%.
• Tracing ELDN's Other Working Capital Changes over 5 years: stood at -$93000.0 in 2022, then dropped by 3.23% to -$96000.0 in 2023, then advanced by 6.25% to -$90000.0 in 2024, then climbed by 10.0% to -$81000.0 in 2025, then retreated by 6.17% to -$86000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$86000.0 (Q1 2026), -$81000.0 (Q4 2025), and -$81000.0 (Q3 2025), per Business Quant data.